Amiodarone neurotoxicity: the other side of the medal

Abstract

<jats:title>Abstract</jats:title><jats:p>The efficacy of amiodarone is tempered by its toxicity, with 50% of long-term users discontinuing the drug. The non-cardiac side effects of amiodarone may involve central and peripheral nervous system. We studied two patients treated with amiodarone for 46 and 15 months respectively. Both patients exhibited progressive distal extremity weakness, impaired perception, loss of deep reflexes. Electrophysiology identified a widespread, sensorimotor polyneuropathy with features of axonal loss and demyelination. Visual evoked potentials (VEPs) showed prolonged P100 latency bilaterally in absence of visual symptoms or brain magnetic resonance imaging (MRI) abnormalities. Extensive laboratory examinations excluded known causes of peripheral neuropathies. At 21 months after amiodarone withdrawal, P100 latency of case 1 VEPs returned to normal, whereas polyneuropathy continued to progress. In the second patient neuropathy has worsened similarly over 2 years whereas P100 latency of VEPs recovered to normal within 7 months after withdrawal of amiodarone. These findings may suggest different mechanisms of toxicity, which could be due to amiodarone pharmacokinetic and its metabolite effects on the peripheral nerves, as opposed to the optic nerve. We emphasize that use of amiodarone needs monitoring of patients at risk of development side effects.</jats:p>

Amiodarone‐Induced Neuropathy with chronic inflammatory demyelinating polyneuropathy‐like presentation

“…The long half-life of amiodarone (up to 100 days) can lead to slow recovery following the discontinuation of the drug. 10 In conclusion, chronic use of amiodarone may present as a CIDPlike presentation, which may be overlooked if clinical suspicion is not high upon presentation. Early suspicion and diagnosis may avert irreversible side effects.…”

Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease

“…Administration of the dopamine agonist Pramipexole increased the risk of heart failure [ 171 ]. Conversely, Amiodarone, an antiarrhythmic medication, has been shown to have neurotoxic effects associated with tremors and Parkinsonism [ 172 , 173 ]. Cinnarizine and Flunarizine—calcium channel blocking drugs frequently used to treat angina, high blood pressure, and arrhythmia—induced movement disorders, Parkinsonism, and depression in 34% of patients [ 174 ].…”

Remodelling in atrial fibrillation: the impact of amiodarone

“…The complex electrophysiological action of this drug is also accompanied by the anti-arrhythmic effect via other mechanisms, incompletely elucidated, such as the interference with the action of thyroid hormones (inhibition of their action at the cardiac level) in the modulation of the effects of the autonomic nervous system. 29…”